Biotech In A Doldrums: Rallies Interrupted By Geopolitics, Trump Agenda And Flight To Safety
April 11, 2017 at 20:38 PM EDT
Recent geopolitical news has created a backdrop that has discouraged investors in biotech who were already risk averse from drug pricing issues. There has been little momentum over since mid-march with choppy sluggish trading.